CAB

BioAtla to Announce First Quarter 2023 Financial Results and Provide Business Highlights on May 11, 2023

Retrieved on: 
Jeudi, mai 4, 2023
Conditional, Webcast, Therapy, CAB, SAN, Pharmaceutical industry

SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference call and webcast on Thursday, May 11, 2023 at 4:30 p.m.

Key Points: 
  • SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference call and webcast on Thursday, May 11, 2023 at 4:30 p.m.
  • ET to discuss its financial results for the quarter ended March 31, 2023 and provide business highlights.

CAB Worldwide LLC Announces Growth Investment

Retrieved on: 
Mercredi, mai 3, 2023
Nestell Kipp Anderson, Partnership, CAB, Kilpatrick Townsend & Stockton, Culture, BKS, Carr, Riggs & Ingram, PNC Financial Services, Steel, Quality, GZA, Iron, HR, Biophysical environment, Growth, Rail transport, Insurance

BUFORD, Ga., May 3, 2023 /PRNewswire/ -- CAB Worldwide LLC ("CAB" or the "Company"), a global engineering, manufacturing and supply chain management business that provides precision machined steel, iron and aluminum cast, forged and fabricated components and assemblies to original equipment manufacturers and distributors, is pleased to announce that it has successfully completed a growth recapitalization led by Heritage Growth Partners LLC ("Heritage Growth"), a private family investment office.

Key Points: 
  • BUFORD, Ga., May 3, 2023 /PRNewswire/ -- CAB Worldwide LLC ("CAB" or the "Company"), a global engineering, manufacturing and supply chain management business that provides precision machined steel, iron and aluminum cast, forged and fabricated components and assemblies to original equipment manufacturers and distributors, is pleased to announce that it has successfully completed a growth recapitalization led by Heritage Growth Partners LLC ("Heritage Growth"), a private family investment office.
  • We are excited to enter this next phase of growth and work in partnership with Heritage Growth.
  • "We are excited to enter this next phase of growth and work in partnership with Heritage Growth."
  • Heritage Growth Managing Partner, Alex Mammen, who has joined the Board of CAB, added, "We look forward to working with Terri and the entire CAB team to help them reach their growth objectives and better serve their customers.

Cannabix Technologies Files Contact-Free Breath Patent Application and Updates on Development and Certification Plans

Retrieved on: 
Mercredi, mai 3, 2023
Data management, Amazon Web Services, JAMA, CSE, Blood, CAB, Infrastructure Investment and Jobs Act, MADD, Electronics, Vehicle, Workplace, Organic compound, IIJA, National Highway Traffic Safety Administration, Volatile organic compound, BAC, Mothers Against Drunk Driving, PCT, Certification, Mother, American Medical Association, Organization, Occupational Safety and Health Act 1994, Journal, Work, Representative, Restaurant, Patent, Alcohol, Algorithm, OTC, BCU, Blood alcohol content, AI, Louisiana House of Representatives, THC, House, AWS, Safety, Legislation, Software, Mobile phone, Rail transport, Medical device

This PCT application was the next step in converting the Company’s provisional patent filed in 2022 related to contactless breath sampling technology.

Key Points: 
  • This PCT application was the next step in converting the Company’s provisional patent filed in 2022 related to contactless breath sampling technology.
  • Due to the encouraging usage results and unique market position of the CAB device, Cannabix has begun efforts to build a commercial workplace CAB unit for certification.
  • The CAB device joins the Company’s portfolio of marijuana breath testing technologies under development.
  • This includes our handheld Breath Collection Unit (BCU) for THC, THC Breath Analyzer (THCBA) and Contactless Alcohol Breathalyzer (CAB).

Find Therapeutics welcomes Dr. Jack Antel to its clinical advisory board

Retrieved on: 
Lundi, mai 1, 2023
Sclerosis, Optic neuritis, Multiple Sclerosis Journal, Cleveland Clinic, Specialist, University, CAB, National Multiple Sclerosis Society, Clinical trial, KNEEMO Initial Training Network, American Academy, Research, University of Ottawa Heart Institute, Department of Neurology, Xuanwu hospital, Multiple sclerosis, MS, Teaching hospital, Multiple Sclerosis Society, Neuro-ophthalmology, Patient, Montreal Neurological Institute and Hospital, University of Genoa, McGill University Health Centre, Soft tissue injury, McGill University, ISCB Senior Scientist Award, Ottawa Hospital Research Institute, Neurosurgery, American Academy of Neurology, Therapy, International Society, Pharmaceutical industry, Management, Medical device, Neurology, Biostatistics

MONTREAL, May 1, 2023 /PRNewswire/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced the appointment of Dr. Jack Antel to its Clinical Advisory Board (CAB).

Key Points: 
  • MONTREAL, May 1, 2023 /PRNewswire/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced the appointment of Dr. Jack Antel to its Clinical Advisory Board (CAB).
  • Dr. Antel joins a CAB with considerable expertise in neuro-ophthalmology whose members have decades of clinical practice with optic neuritis patients as well as clinical trial expertise and peer-reviewed publications in this condition.
  • Dr. Antel is an internationally acclaimed clinical neurologist and thought leader who coordinates the multiple sclerosis research and treatment program at the Montreal Neurological Institute.
  • "We are honored and delighted to welcome Dr. Antel to our Clinical Advisory Board.

ATX ‘2050 Project’ Cable Industry Survey Reveals Growing Momentum for DOCSIS 4.0

Retrieved on: 
Mardi, avril 25, 2023
Carriers and Services, Mobile, Wireless, Networks, Internet, Hardware, Consumer Electronics, IOT (Internet of Things), Technology, Trucking, Transport, Other Technology, Logistics, Supply Chain Management, Telecommunications, CAB, Life, DOCSIS, PON, Customer advisory council, Intelligence, CALA, Multimedia, ATX, DAA, Organization, Plant, Extended-spectrum penicillin, HFC, Investment, Hybrid fiber-coaxial, FTTH, ESD, Hybrid, MSO, Cable television, Renewable energy

View the full release here: https://www.businesswire.com/news/home/20230425005141/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230425005141/en/
    ATX 2050 survey uncovers increased support for the Extended Spectrum DOCSIS (ESD) version of DOCSIS 4.0.
  • (Graphic: Business Wire)
    Now in its third year, the 2023 edition of the survey uncovered increased support for the Extended Spectrum DOCSIS® (ESD) version of DOCSIS 4.0.
  • The 2023 edition of the 2050 Project Survey draws on the opinions of nearly 100 cable professionals from roughly 60 organizations, the majority of which are located in North America.
  • In addition to the 2050 Project Survey, ATX regularly consults with its Customer Advisory Board (CAB) to gain insight into the future direction of the cable industry.

SAI.TECH Announces its Annual Presentation ‘SAITIME 2023’ with New Products and Projects Launching

Retrieved on: 
Jeudi, avril 20, 2023
Bitcoin, Blockchain, Stratos Global Corporation, Small modular reactor, CAB, Noise, Survival, Electric power distribution, Vegetable, SAI, Stage One, Lightning, Wind, Rolls-Royce SMR, The Company, Mining, PCB, Dust, BOX, SMR, ESG, Heat, AI, ASIC, Cryptocurrency, Renewable energy

ULTIAAS consists of two parts, a series of products for turnkey solution and operation part for cloud services.

Key Points: 
  • ULTIAAS consists of two parts, a series of products for turnkey solution and operation part for cloud services.
  • It is noteworthy that SAI.TECH first officially revealed to the public its latest infrastructure products, TANKBOX, RACKBOX and HYDROBOX.
  • The other part of ULTIAAS is operation which is the design, construction, and operation of sustainable and high-performance data center projects.
  • Stage One plan is divided into 5 steps, Trading Dominance, Mining Globalization, Electricity Infrastructure, Chip Fabrication and Interstellar Deployment.

ScaleWith Forms Advisory Boards to Advance Industry Standards for Social Impact Measurement, Reporting, & Verification

Retrieved on: 
Mercredi, avril 19, 2023
Technology, Other Technology, Professional Services, Philanthropy, Software, DEI (Diversity, Equity and Inclusion), Environmental, Social and Governance (ESG), Other Philanthropy, Data Management, CBS Corporation, Central Waqf Council, RFP, STEAM, IBM, Software as a service, Viacom, CAB, Thunder, Education, Customer advisory council, A.I, Equity, CSR, Public sector, Organization, Coforge, Health, ESG, TAB, Salesforce, Accenture, Video game, Paramount

ScaleWith, Inc., a market-making SaaS technology company that embeds social impact funding into B2B and public sector transactions, today announced the formation of its Customer Advisory Board (CAB) to advance industry standards for measurement, reporting, and verification of social impact and corporate ESG initiatives.

Key Points: 
  • ScaleWith, Inc., a market-making SaaS technology company that embeds social impact funding into B2B and public sector transactions, today announced the formation of its Customer Advisory Board (CAB) to advance industry standards for measurement, reporting, and verification of social impact and corporate ESG initiatives.
  • ScaleWith transforms social impact from a cost center into a revenue generator by embedding new funding for sustainability and social impact into B2B and public sector transactions.
  • SellWith Pro > social impact funding platform for small and fast-growing businesses looking to efficiently use social impact funding as an additional incentive in commercial transactions;
    SellWith Select > social impact funding platform with an enhanced recommendation engine for ScaleWith’s proprietary network of social impact partners; and
    SellWith Enterprise > social impact funding platform with an advanced recommendation engine and access to ScaleWith’s award-winning engagement content library.
  • Customers using SellWith and BuyWith are able to select social impact funding recipients from GiveWith, ScaleWith’s proprietary network of 140+ Social Impact Partners delivering 400+ programs worldwide.

Multifamily Development of the Year “The Sutton” Celebrates Grand Opening

Retrieved on: 
Mercredi, avril 5, 2023
Commercial Building & Real Estate, Construction & Property, Urban Planning, REIT, Landscape, Building Systems, Restaurant, Bar, Architecture, Retail, Residential Building & Real Estate, Lease, Scioto Greenway Trail, CAB, Willamette River, Portland Art Museum, COVID-19, Commercial property, Fremont Bridge, TVA, Greenway, Golden Joystick Awards, Pearl, Lincoln, NanoBusiness Commercialization Association, Coffee, Growth, General contractor, Pedestrian, Fremont Bridge (Portland, Oregon)

The Sutton is a 17-story residential tower located on the Willamette River in the North Pearl neighborhood.

Key Points: 
  • The Sutton is a 17-story residential tower located on the Willamette River in the North Pearl neighborhood.
  • The building’s “front yard” is on the Greenway Trail—which provides public access to the river and Portland’s iconic trail system.
  • The Sutton also features space for a ground-floor restaurant with indoor/outdoor seating along the waterfront that will bring the community together.
  • As part of the opening ceremony, Patrick Gilligan, Executive Vice President with Lincoln, and Nick Gonzalves, Director with Bridge Investment Group, marked the property’s official opening with a formal ribbon cutting.

Health Recovery Solutions Announces New Client Advisory Board

Retrieved on: 
Mardi, mars 28, 2023
CAB, Information technology, HRS, KLAS, CommonSpirit Health, Hospice, Organization, Nursing, RPM, Health, Pharmaceutical industry

HOBOKEN, N.J., March 28, 2023 /PRNewswire/ -- Health Recovery Solutions (HRS), the KLAS leader in remote patient monitoring (RPM), today announced the launch of a Client Advisory Board (CAB), comprised of the healthcare industry's most innovative and experienced leaders. The new CAB will provide strategic guidance as HRS brings new products and services to the market, focused on improving patient outcomes and expanding access to care.

Key Points: 
  • HOBOKEN, N.J., March 28, 2023 /PRNewswire/ -- Health Recovery Solutions (HRS), the KLAS leader in remote patient monitoring (RPM), today announced the launch of a Client Advisory Board (CAB), comprised of the healthcare industry's most innovative and experienced leaders.
  • Health Recovery Solutions prioritized both professional and personal diversity of its Client Advisory Board.
  • "The individuals and organizations serving on our inaugural Client Advisory Board are setting the standard for care delivery using digital health platforms—specifically remote patient monitoring," said Kimberly O'Loughlin, Chief Executive Officer at Health Recovery Solutions.
  • "It's an honor to be a member of Health Recovery Solutions' Client Advisory Board and to have the opportunity to engage with innovators in the digital health space," said Anna Ferguson, Chief Operations and Nursing Officer at Camillus Health Concern.

BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress

Retrieved on: 
Jeudi, mars 23, 2023
TIP, TMP, AACR, Therapy, CAB, LMS, Nivolumab, Metastasis, ESMO, Liquid biopsy, DLT, Progression-free survival, G&A, Oncology, Research, Lung cancer, ELCC, PFS, European Society for Medical Oncology, Conditional, FPI, Congress, American Association for Cancer Research, Soft tissue, EGFR, SAN, Webcast, UPS, Observation, Spacecraft, European Society of Gynaecological Oncology, R, FDA, IND, ORR, Food, Safety, ALK, Vaccine, Pharmaceutical industry, Nursing, Cryptocurrency, NSCLC, Patient

Research and development (R&D) expenses were $21.9 million for the quarter ended December 31, 2022 compared to $16.5 million for the same quarter in 2021.

Key Points: 
  • Research and development (R&D) expenses were $21.9 million for the quarter ended December 31, 2022 compared to $16.5 million for the same quarter in 2021.
  • General and administrative (G&A) expenses were $6.7 million for the quarter ended December 31, 2022 compared to $7.0 million for the same quarter in 2021.
  • Net loss for the quarter ended December 31, 2022 was $27.5 million compared to a net loss of $23.4 million for the same quarter in 2021.
  • Net loss for the full year 2022 was $106.5 million as compared to a net loss of $95.4 million in 2021.